Clinical Trials Logo

Filter by:
NCT ID: NCT00295165 Terminated - Crohn Disease Clinical Trials

Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's Disease

Start date: January 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate if Leukine can induce clinical response or remission in patients with Crohn's disease.

NCT ID: NCT00294983 Withdrawn - Burns Clinical Trials

OCD Among Patients With Burns

Start date: n/a
Phase: N/A
Study type: Observational

Estimating the prevalence of OCD symptoms among patients with burns

NCT ID: NCT00294970 Completed - Clinical trials for Obsessive-Compulsive Disorder

Cognitive Characteristics of PTSD Patients With OCD

Start date: February 2006
Phase: N/A
Study type: Observational

Cognitive profile of patients who suffer both from PTSD and OCD, as compared to those who suffer from PTSD or OCD without other comorbidity.

NCT ID: NCT00294957 Withdrawn - PTSD Clinical Trials

Psychological and Physiological Status of Former Prisoners of War

Start date: n/a
Phase: N/A
Study type: Observational

Assessing the psychological and physiological status of Israeli former prisoners of war (POW).

NCT ID: NCT00294944 Withdrawn - Clinical trials for Major Depressive Disorder

The Effectiveness of Idazoxan in Treating TRD

Start date: n/a
Phase: Phase 3
Study type: Interventional

Assessing the effectiveness of Idazoxan as a treatment for depressive patients who did not respond to treatment with SSRI

NCT ID: NCT00294840 Completed - Pancreatic Cancer Clinical Trials

Dynamic PET acquisition-a Quantitative Technique for Grading of Malignant Tumors and Prediction of Response to Treatment

Start date: August 2006
Phase: Phase 0
Study type: Observational

To assess a quantitative kinetic model of FDG uptake measurement using PET in patients with aggressive Non-Hodgkin's lymphoma and cancer of the pancreas, malignancies with known variability in disease aggressiveness and prognosis, for optimized tailoring of the therapeutic strategy in the individual patient.

NCT ID: NCT00294814 Recruiting - Clinical trials for Postoperative Complications

TCD Detection of Gas and Solid Micro-Emboli in Patients Undergoing Coronary Artery Bypass Grafting (CABG): The Influence of Proximal Anastomosis Technique

Start date: n/a
Phase: N/A
Study type: Interventional

The purpose of this study is to test the hypothesis that using three different techniques to anastomose coronary grafts to the aorta: partial occlusion, single cross clamp, or using the Heartstring anastomotic device, will change the amount of gas and solid microemboli as detected by the EmbodopR transcranial Doppler (TCD) system and consequently the neurocognitive performance of patients after coronary bypass operation.

NCT ID: NCT00294801 Recruiting - Osteoarthritis Clinical Trials

Effect of Flex-a-New on Osteoarthritis of the Knee

Start date: January 2006
Phase: Phase 4
Study type: Interventional

comparative trial of placebo versus flex-a-new (a food supplement) containing glucosamine an chondroitin sulfate for the symptom modification is knee osteoarthritis

NCT ID: NCT00294489 Recruiting - Clinical trials for Chronic Hepatitis C Virus Infection

Methacetin Breath Test in HCV Patients With Normal and Near-Normal ALT

Start date: February 2006
Phase: Phase 3
Study type: Observational

A relatively large proportion of patients with chronic HCV infection have normal or mildly elevated ALT. Many of these patients are not being treated, and are not being sent for a liver biopsy. The present study will determine the ability of Methcetin BreathID Test(MBIT) to detect those patients who will be candidates for anti-viral treatment, as an alternative measure for liver biopsy in decision-making prior to treatment in clinical hepatology.

NCT ID: NCT00294476 Recruiting - Malignant Melanoma Clinical Trials

IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and Melanoma

Start date: July 2005
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of IVIG in the treatment of metastatic cancer of the prostate, colon and melanoma.